Akero Therapeutics Inc


Market Cap$1.7B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Akero Therapeutics IncAkero Therapeutics Inc00%---

Target Price by Analysts

105.1% upsideAkero Therapeutics Target Price DetailsTarget Price

Current Fair Value

81.8% downside

Overvalued by 81.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$1.70 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares69,151,007
Avg 30 Day Volume846,475


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales-
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income-
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Akero Therapeutics Inc